Search Results - "Haslund, Charlotte"

Quality of life and mental health in real-world patients with resected stage III/IV melanoma receiving adjuvant immunotherapy by Pedersen, Sidsel, Holmstroem, Rikke B, von Heymann, Annika, Tolstrup, Laerke K, Madsen, Kasper, Petersen, Morten Aagaard, Haslund, Charlotte A, Ruhlmann, Christina H, Schmidt, Henrik, Johansen, Christoffer, Svane, Inge Marie, Ellebaek, Eva

“…Treatment with immune checkpoint inhibitors (ICI) has expanded into the adjuvant setting enhancing the importance of knowledge on the immune-related toxicities…”
Get more information

Outcome of adjuvant immunotherapy in a real-world nation-wide cohort of patients with melanoma by Holmstroem, Rikke B., Pedersen, Sidsel, Jurlander, Rebecca, Madsen, Kasper, Donia, Marco, Ruhlmann, Christina H., Schmidt, Henrik, Haslund, Charlotte A., Bastholt, Lars, Svane, Inge Marie, Ellebaek, Eva

“…Clinical trials have demonstrated promising outcomes for adjuvant immunotherapy in patients with resected melanoma. Real-life data provide valuable insights to…”
Get full text

Immune-related adverse events in a nationwide cohort of real-world melanoma patients treated with adjuvant anti-PD1 – Seasonal variation and association with outcome by Jurlander, Rebecca Schou, Guldbrandt, Louise Mahncke, Holmstroem, Rikke B., Madsen, Kasper, Donia, Marco, Haslund, Charlotte A., Schmidt, Henrik, Bastholt, Lars, Ruhlmann, Christina H., Svane, Inge Marie, Ellebaek, Eva

“…Immune checkpoint inhibitors (ICIs) carry the risk of immune-related adverse events (irAEs), a significant concern as therapy has transitioned to the adjuvant…”
Get full text

Seasonal variation in effect of anti‐PD‐1 initiation on overall survival among patients with advanced melanoma by Ellebaek, Eva, Schina, Aimilia, Schmidt, Henrik, Haslund, Charlotte Aaquist, Bastholt, Lars, Svane, Inge Marie, Donia, Marco

“…Melanoma is a highly immunogenic cancer, and circannual rhythms influence the activity of the immune system. We retrospectively collected information on all…”
Get full text

Patterns of care and survival in patients with multifocal glioblastoma: A Danish cohort study by Trip, Anouk Kirsten, Hedegaard Dahlrot, Rikke, Aaquist Haslund, Charlotte, Muhic, Aida, Rosendal Korshøj, Anders, Laursen, René Johannes, Rom Poulsen, Frantz, Skjøth-Rasmussen, Jane, Lukacova, Slavka

“…This Danish cohort study aims to (1) compare patterns of care (POC) and survival of patients with multifocal glioblastoma (mGBM) to those with unifocal…”
Get full text

Treatment plan comparison of proton vs photon radiotherapy for lower-grade gliomas by Byskov, Camilla S., Hansen, Christian R., Dahlrot, Rikke H., Haldbo-Classen, Lene, Haslund, Charlotte A., Kjær-Kristoffersen, Flemming, Kristensen, Thomas O., Lassen-Ramshad, Yasmin, Lukacova, Slávka, Muhic, Aida, Nyström, Petra W., Weber, Britta, Kallehauge, Jesper F.

“…Patients with lower-grade gliomas are long-term survivors after radiotherapy and may benefit from the reduced dose to normal tissue achievable with proton…”
Get full text

The Danish metastatic melanoma database (DAMMED): A nation-wide platform for quality assurance and research in real-world data on medical therapy in Danish melanoma patients by Ellebaek, Eva, Svane, Inge Marie, Schmidt, Henrik, Haslund, Charlotte Aaquist, Donia, Marco, Hoejberg, Lise, Ruhlmann, Christina, Guldbrandt, Louise Mahncke, Køhler, Ulrich Heide, Bastholt, Lars

“…•The Danish Metastatic Melanoma Database is a nationwide registry for medical therapy.•Disease registries are crucial to evaluate safety and efficacy of new…”
Get full text

ProTarget: a Danish Nationwide Clinical Trial on Targeted Cancer Treatment based on genomic profiling - a national, phase 2, prospective, multi-drug, non-randomized, open-label basket trial by Kringelbach, Tina, Højgaard, Martin, Rohrberg, Kristoffer, Spanggaard, Iben, Laursen, Britt Elmedal, Ladekarl, Morten, Haslund, Charlotte Aaquist, Harsløf, Laurine, Belcaid, Laila, Gehl, Julie, Søndergaard, Lise, Eefsen, Rikke Løvendahl, Hansen, Karin Holmskov, Kodahl, Annette Raskov, Jensen, Lars Henrik, Holt, Marianne Ingerslev, Oellegaard, Trine Heide, Yde, Christina Westmose, Ahlborn, Lise Barlebo, Lassen, Ulrik

“…An increasing number of trials indicate that treatment outcomes in cancer patients with metastatic disease are improved when targeted treatments are matched…”
Get full text

Comparison of Efficacy in Patients with Metastatic Melanoma Treated with Ipilimumab and Nivolumab Who Did or Did Not Discontinue Treatment Due to Immune-Related Adverse Events: A Real-World Data Study by Fink, Morten, Vittrup, Anders Schwartz, Bastholt, Lars, Svane, Inge Marie, Donia, Marco, Luczak, Adam A., Ruhlmann, Christina H., Guldbrandt, Louise Mahncke, Koehler, Ulrich Heide, Winther, Mette Lerche, Ellebaek, Eva, Haslund, Charlotte Aaquist, Schmidt, Henrik

“…Immune-related adverse events (irAEs) are very prevalent when treating patients with ipilimumab and nivolumab in combination, and 30–40% of patients…”
Get full text

PD-L1 is a biomarker of real-world clinical outcomes for anti-CTLA-4 plus anti-PD-1 or anti-PD-1 monotherapy in metastatic melanoma by Ellebaek, Eva, Khan, Shawez, Bastholt, Lars, Schmidt, Henrik, Haslund, Charlotte Aaquist, Donia, Marco, Svane, Inge Marie

“…Metastatic melanoma (MM) is commonly treated with a combination of nivolumab and ipilimumab, regardless of tumor PD-L1 expression. We conducted a…”
Get full text

2301: Two-level mixed effect model to predict image changes after proton therapy of brain tumours by Vestergaard, Anne, Kallehauge, Jesper, Muhic, Aida, Carlsen, Jonathan Frederik, Dahlrot, Rikke, Lukacova, Slavka, Haslund, Charlotte, Worawongsakul, Rasin, Høyer, Morten

Get full text

Does patient sex affect the treatment outcome of immune checkpoint inhibitors? A Danish, observational melanoma study by Petersen, Soeren Kjaer, Hansen, Christian Rønn, Ellebaek, Eva, Schmidt, Henrik, Haslund, Charlotte Aaquist, Ruhlmann, Christina H., Bastholt, Lars

“…The objective of this study was to evaluate whether patient biological sex influences treatment outcomes in patients with metastatic melanoma (MM) undergoing…”
Get full text

Sustained improved survival of patients with metastatic melanoma after the introduction of anti-PD-1-based therapies by Schina, Aimilia, Pedersen, Sidsel, Spenning, Anne-Louise, Laursen, Olivia Kaas, Pedersen, Cecilia, Haslund, Charlotte Aaquist, Schmidt, Henrik, Bastholt, Lars, Svane, Inge Marie, Ellebaek, Eva, Donia, Marco

“…BACKGROUNDThe introduction of modern therapies improved the median survival of patients with metastatic melanoma (MM). Here, we determined the real-world…”
Get full text

SURG-32. OPTIMIZING TUMOR TREATING FIELDS THERAPY FOR FIRST RECURRENT GLIOBLASTOMA WITH SKULL REMODELING SURGERY. FINAL RESULTS FROM OPTIMALTTF-2, A MULTI-CENTER, RANDOMIZED, CLINICAL TRIAL by Mikic, Nikola, Skjøth-Rasmussen, Jane, Poulsen, Frantz Rom, Laursen, Rene Johannes, Lukacova, Slavka, Møller, Søren, Haslund, Charlotte Aaquist, Dahlrot, Rikke Hedegaard, Solheim, Ole Skeidsvoll, Solheim, Tora Skeidsvoll, Sørensen, Jens Christian Hedemann, Wong, Eric T, Korshøj, Anders Rosendal

“…Abstract Studies indicate that increasing the electric field intensity of Tumor Treating Fields therapy (TTFields) may prolong survival for glioblastoma (GBM)…”
Get full text

Final overall survival and long-term safety in the ENGOT-OV16/NOVA phase III trial of niraparib in patients with recurrent ovarian cancer (LBA 6) by Matulonis, Ursula, Herrstedt, Jørn, Oza, Amit, Mahner, Sven, Redondo, Andres, Berton, Dominique, Berek, Jonathan, Haslund, Charlotte, Marmé, Frederik, González-Martín, Antonio, Becourt, Stéphanie, Tinker, Anna, Ledermann, Jonathan, Benigno, Benedict, Lindahl, Gabriel, Colombo, Nicoletta, Malinowska, Izabela, Liu, Wenlei, Schmitz, Michael, Monk, Bradley, Mirza, Mansoor

Get full text

Frequency and characteristics of immune-related thyroid adverse events in patients with resected stage III/IV melanoma treated with adjuvant PD-1 inhibitors: a national cohort study by Christensen, Stine K., Winther, Mette L., Laursen, Ida J., Madsen, Freja S., Brink, Carsten, Brix, Thomas H., Ellebaek, Eva, Svane, Inge Marie, Hansen, Frederikke S., Haslund, Charlotte, Laursen, Olivia K., Schmidt, Henrik, Larsen, Ida D., Bastholt, Lars, Ruhlmann, Christina H.

“…Purpose Immune-related thyroid adverse events (irTAEs) occur frequently following immune checkpoint inhibitor (ICI) therapy. The purpose of this study is to…”
Get full text

A national study on the inter-observer variability in the delineation of organs at risk in the brain by Lorenzen, Ebbe Laugaard, Kallehauge, Jesper Folsted, Byskov, Camilla Skinnerup, Dahlrot, Rikke Hedegaard, Haslund, Charlotte Aaquist, Guldberg, Trine Lignell, Lassen-Ramshad, Yasmin, Lukacova, Slávka, Muhic, Aida, Witt Nyström, Petra, Haldbo-Classen, Lene, Bahij, Ihsan, Larsen, Lone, Weber, Britta, Hansen, Christian Rønn

“…The Danish Neuro Oncology Group (DNOG) has established national consensus guidelines for the delineation of organs at risk (OAR) structures based on published…”
Get more information

Feasibility and early clinical impact of precision medicine for late-stage cancer patients in a regional public academic hospital by Ladekarl, Morten, Nøhr, Anne Krogh, Sønderkær, Mads, Dahl, Simon Christian, Sunde, Lone, Vestereghem, Charles, Mapendano, Christophe Kamungu, Haslund, Charlotte Aaquist, Pagh, Anja, Carus, Andreas, Lörincz, Tamás, Nowicka-Matus, Kinga, Poulsen, Laurids Ø, Laursen, René Johannes, Dybkær, Karen, Poulsen, Birgitte Klindt, Frøkjær, Jens Brøndum, Brügmann, Anja Høegh, Ernst, Anja, Wanders, Alkwin, Bøgsted, Martin, Pedersen, Inge Søkilde

“…Our goal was to describe a precision medicine program in a regional academic hospital, characterize features of included patients and present early data on…”
Get more information

Preliminary phase II results of selinexor, an oral selective inhibitor of nuclear export in patients with heavily pretreated gynecological cancers by Vergote, Ignace, Lund, Bente, Havsteen, Hanne, Ujmajuridze, Zaza, Leunen, Karin, Aaquist Haslund, Charlotte, Juhler-Noettrup, Trine, Roed, Henrik, Rashal, Tami, Kranich, Anne L., Landesman, Yosef, Saint-Martin, Jean-Richard, Carlson, Robert, Shacham, Sharon, Kauffman, Michael, Mirza, Mansoor Raza

“…Abstract only…”
Get full text